News

Exciting Changes at Cannara Biotech with New Board Member

Exciting Changes at Cannara Biotech with New Board Member

Welcoming a New Visionary to the Board of Cannara Biotech

MONTREAL — Cannara Biotech Inc. (“Cannara”, “the Company”, “we”) (TSXV: LOVE) (OTCQB: LOVFF) is excited to announce the recent addition of Justin Cohen to its board of directors as an independent director. This marks a significant move for Cannara as it aims to amplify its presence in the competitive cannabis market.

Justin Cohen’s Impressive Background

Mr. Justin Cohen brings a wealth of experience to his new role. As a former Chief Marketing and Chief Commercial Officer at Psycho Bunny, he played a pivotal role in transforming the brand from a niche entity into a global leader. His initiatives led to a remarkable tenfold increase in revenue within three years, driven by innovative retail expansion and digital marketing strategies.

Strategic Leadership and Experience

Before his tenure at Psycho Bunny, Cohen's strategic foresight was evident as he led e-commerce initiatives at Keurig Dr Pepper, enhancing its digital marketplace presence. His impressive track record includes leadership positions at renowned companies like Google, ALDO Group, and Sony Music, where he focused on brand evolution and digital transformation.

Current Initiatives and Future Plans

Currently, Cohen is making waves as a senior executive at Cosmetic Physician Partners, overseeing marketing efforts for a portfolio comprising over 55 clinics across the United States. Additionally, he provides critical guidance to Dose Juice on commercial strategies and operational efficiencies. Cohen's robust educational background includes degrees in Marketing & Advertising, an MBA, and a master’s in behavioral science from the London School of Economics, demonstrating his commitment to strategic growth and brand management.

A Word from the Leadership Team

The CEO of Cannara, Zohar Krivorot, expressed enthusiasm about the new addition, stating, “We are thrilled to welcome Justin to our Board. His wealth of experience in brand development and digital transformation aligns seamlessly with Cannara’s mission to elevate our flagship brands — Tribal, Nugz, and Orchid CBD — as leaders in the Canadian cannabis market. Justin’s strategic insights are set to significantly bolster our operational growth and enhance our market presence.”

Justin Cohen's Commitment

In his statement, Mr. Cohen reflected on the opportunity with enthusiasm: “I am honored to join Cannara’s Board of Directors. The Company has made a strong commitment to quality and innovation in the cannabis industry. I am eager to leverage my experience in brand strategy and digital innovation to support Cannara’s growth trajectory.”

About Cannara Biotech

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) is recognized as a leader in the Canadian cannabis market. With two state-of-the-art facilities located in Québec, spanning over 1,650,000 sq. ft., Cannara distinguishes itself by producing premium-grade cannabis products that remain affordable for consumers. Leveraging the region’s low electricity costs, Cannara aims to provide high-quality cannabis offerings while ensuring that sustainability and accessibility remain at the forefront of their production practices.

With a strong foundation and clear direction, Cannara Biotech is well-positioned to navigate the complexities of the cannabis industry, ensuring that they not only meet current market demands but also drive forward-thinking practices in cultivation and sales.

Frequently Asked Questions

1. Who is the new board member of Cannara Biotech?

The new board member is Justin Cohen, who brings extensive experience in brand development and digital strategy.

2. What are Justin Cohen's previous roles before Cannara?

He has held significant positions at Psycho Bunny, Keurig Dr Pepper, Google, ALDO Group, and Sony Music, focusing on marketing and commercial strategies.

3. How does Cannara Biotech plan to expand?

Cannara plans to use Justin Cohen's expertise in digital transformation and branding to grow its market presence and brand equity.

4. What are Cannara's flagship brands?

Cannara's flagship brands include Tribal, Nugz, and Orchid CBD, which are positioned as leading cannabis brands in Canada.

5. How does Cannara emphasize sustainability?

Cannara leverages Québec's low electricity costs to produce premium-grade cannabis products affordably, focusing on sustainable practices in cultivation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 90

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
Greenworks Giveaway Powers Lawn Pros with $34K in Gear

Updated Category News Views 45

Big Wins for Small Operations: The Greenworks Gamble Here's something that'll make any grass-whisperer perk up. Greenworks® Commercial, known for their battery-centered machinery, juiced some serious goodwill at the Equip Exposition 2026. They coughed up nearly $34,000 in gear, dishing out prizes like really expensive candy at a lawn-care carnival. Lucky Draw Brings...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 71

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
Xi's Financial Vision: China's Path to Global Power

Updated Category News Views 0

China's Grand Financial Strategy Alright, strap in as President Xi Jinping is back on the scene painting a bold picture for China's financial future. The guy doesn't mess around when he says finance is a linchpin for the country's modernization. China's got the pedal to the metal, aiming to transform its national clout into a financial juggernaut. Key Pillars of Financial...

Continue Reading
EClinCloud Targets Better FDA Compliance with AI Boost

Updated Category News Views 16

FDA Citations Under the Microscope Here we are, wading through another layer of clinical research nitty-gritty, and it's bringing clinical processes under a sharper lens. EClinCloud just dropped a hefty analysis on 1,715 FDA Bioresearch Monitoring citations. Turns out, protocol compliance, informed consent, and case histories chew up 46.2% of these citations. Sounds like...

Continue Reading
SPECS Framework: Rethinking Career Growth Strategies

Updated Category News Views 39

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Continue Reading
Northwind Backs Huge Office-to-Residential Overhaul

Updated Category News Views 159

In the Heart of Midtown: A Major Overhaul I'm telling ya, if there's a piece of news that makes me sit up straight this morning over the breakfast bar, it's this colossal $231 million construction loan announcement by Northwind Group. They're turning 675 Third Avenue, a towering 32-story office behemoth smack in Midtown, into residential apartments. Right here in...

Continue Reading
Summit Midstream Prepares for Q3 2026 Earnings Report

Updated Category News Views 40

Quarterly financials are the canary in the coal mine for any energy firm. Scrutinizing those numbers can be the difference between riding a bull market or nursing your wounds in a ditch. So, what's on tap for Summit Midstream Corporation (NYSE: SMC)? They've circled November 9, 2026, on the calendar for releasing their third quarter figures, just after the NYSE bell...

Continue Reading
Ultima Genomics Drives Precision Medicine Forward in Singapore

Updated Category News Views 0

A Major Milestone for Precision Medicine Ultima Genomics just nabbed a big one, folks. They're going front and center with Singapore's National Precision Medicine (NPM) Program for Phase III, marking no small feat in the ambitious world of genomics. This is more than just another feather in their cap—it's a power move in the cutthroat race for sequencing supremacy. And...

Continue Reading
YOUTOPIA Fashion Final Fuels Chinese Creative Growth

Updated Category News Views 63

A Melting Pot of Chinese Creative Talent Under the neon glow of Shanghai’s iconic skylines, the 2026 YOUTOPIA Fashion Final became a buzzing hive of creative energy — the kind that prickles your skin and makes you lean in. This ain't just about strutting pretty threads; it's the crucible for tomorrow's fashion titans, the place where raw talent gets its first taste of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exousia Bio Advances Cancer Therapy with New Acquisition

Updated Category News Views 181

Exousia Bio Completes Strategic Acquisition In a significant move for the oncology sector, LAMY announced that it has finalized the acquisition of Exousia AI, Inc., expanding its prowess in exosome-based cancer therapies. This strategic maneuver, which involved the issuance of 62,223,000 shares of common stock, positions the company to leverage a promising preclinical...

Continue Reading
Getaround's Strategic Focus Shift: A Closer Look at Operations

Updated Category News Views 554

Getaround's Strategic Decision to Wind Down U.S. Operations Getaround, Inc., a notable player in the global car-sharing landscape, has made the tough decision to initiate an organized wind-down of its United States business operations. This strategic move will encompass both its car-share services and the HyreCar division, while continuing to strengthen and expand its...

Continue Reading
Pharmacists Mutual Insurance Company Transforms Into Group Structure

Updated Category News Views 294

Exciting Developments for Pharmacists Mutual Insurance Company Pharmacists Mutual Insurance Company, known for its leadership in commercial property and casualty insurance, is embarking on a significant transformation aimed at enhancing its service offerings and operational flexibility. The company is thrilled to announce its restructuring into a limited mutual holding...

Continue Reading
Winsome Resources Advances with Adina Lithium Project Permit Filing

Updated Category News Views 257

Winsome Resources Takes Step Forward with Adina Project Winsome Resources, a company dedicated to lithium exploration and development, proudly announces the submission of the Preliminary Information Statement for its Adina Lithium Project. This pivotal step has been taken in collaboration with the relevant authorities, marking the beginning of a refined provincial...

Continue Reading
Hoth Therapeutics Pioneers Drug-Induced Rash Treatment Solutions

Updated Category News Views 188

Hoth Therapeutics Innovates with HT-001 for Patient Care Hoth Therapeutics is making significant strides in oncology with its innovative drug HT-001, meticulously developed to ease dermatological side effects associated with MENIN inhibitors, a class of oncology drugs gaining traction in treating acute leukemias and specific solid tumors. The aim is to allow patients to...

Continue Reading